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The homologous Cecil-bin~ng proteins calmodulin and skeletal and cardiac troponin C bind in the 
presence of 1 mM Ca2’ to phenyl-Sepharose and can be eluted in buffers containing chelators. Results 
obtained with a series of proteolytic fragments, which were prepared by limited tryptic or thrombic 
degradation, showed that this Ca 2+-dependent hydrophobic interaction chromatography provides a 
convenient method for the large scale purification of some of these peptides. Moreover, it was found that 
in troponin C only one Ca2+ -induced hydrophobic site is located in the amino-terminal half of the protein, 
but that calmodulin contained such sites in both the amino- and carboxy-terminal halves of the molecule. 
The probable location of the latter site is discussed. 
C&/Cd’-dependence ~almodu~in 
Proteolyti~-fragment 
1. INTRODUCTIOl’l 
Calmodulin (GM) is the acidic heat-stable in- 
tracellular modulator protein that confers 
Ca2+-based regulation to a large variety of impor- 
tant enzyme systems in eukaryotic cells (for review 
see [l] and references therein). After the original 
demonstration [2] that binding of phenothiazine 
drugs, like trifluoperazine (TFP), to CaM requires 
the presence of Ca”, various reports have ap- 
peared showing that the same applies for binding 
of several other drugs 13-51, as well as for a series 
of small proteins [6-81. Although it is certainly not 
confirmed at present that the physiological mode 
of action of these drugs is mediated via their bind- 
ing to CaM [9,10], these studies have provided a 
convenient method for the purification of CaM by 
using Ca 2+-dependent affinity chromatography 
with drugs covalently linked to Sepharose beads 
[ 1 l-131. At the same time it was shown by study- 
ing fluorescent enhancement of hydrophobic pro- 
bes that hydrophobic regions were exposed on the 
surface of CaM upon addition of Ca” [ 14,151. As 
well, cadmium-l 13 NMR {la] and calcium-43 
Hydrophobic interaction chromatography 
Troponin C 
NMR [17] indicated that the exchange rate of Ca2’ 
bound to the two weak Ca2+-binding sites 1181 of 
CaM was markedly reduced by addition of TFP or 
other drugs, hence suggesting that conformational 
changes occur upon drug binding, a notion further 
substantiated by recent proton NMR studies [19]. 
Recently, it has become apparent that the 
homologous calcium binding proteins SlOO and 
skeletal troponin C (sTnC) [ 13,201, as well as squid 
proteins [21], can also be purified using similar af- 
finity chromatography. Here, we report that CaM 
and TnC can be purified using Ca2+-dependent 
hydrophobic interaction chromatography on com- 
mercially available phenyl-Sepharose. Moreover, 
results obtained with a series of CaM [l&22-25] 
and sTnC [25-281 proteolytic fragments have pro- 
vided some insight into the location of the 
Ca2+-induced hydrophobic regions on the protein. 
2. MATERIALS AND METHODS 
Phenyl-Sepharose was a product of Pharmacia 
Fine Chemicals (Sweden). 2-Chloro-lo-(3-amino~ 
propyl)-phenothi~ine maleate (CAPP) was 
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obtained from Rhone-Poulenc (France), All other 
chemicals used were highest grade commercial 
products and were as in [18]. 
Bovine testis CaM and rabbit muscle sTnC were 
purified as in ff2,29], whereas cTnC was purified 
from beef-heart using an unpub~sh~d method of 
Stepkowski and Drabikowski. Thrombic frag- 
ments TM1 (l-106) and TM2 (107-148) and the 
carboxy-terminal tryptic fragment TRzC (78-148) 
from CaM were prepared and purified as in [18]. 
The amino-terminal fragment TRtC (l-77) was 
purified in the laboratory of Di C.B. Klee (Natio- 
nal Institutes of Health, 3ethesda MD) on a 
Waters Bondapak Phenyl column using reverse- 
phase ~~-pr~ure liquid ~~omatography essen- 
tially as in [30]. All fragments were judged pure by 
proton NMR, sodium dod~ylsulfate (SDS)- 
polyacrylamide gel electrophoresis [ 181, non- 
denaturing agarose gel electrophoresis [31] and 
amino acid composition determinations and se- 
quence studies. 
Tryptic cleavage of sTnC was performed slightly 
differently, as in [28]. In a typical experiment 
100 mg sTnC was dissolved in 10 ml 50 mM 
N&WCC& 50 mM NaCl, 2 mM CaCL @H 7.8). 
Proteolytic cleavage was initiated by addition of 
250 pl of a t rag/ml TPCK-trypsin (Worthington, 
USA) stock solution in I mM HCl. After 6 h at 
30°C, 5OO/tl of a I mg/ml stock solution of soy- 
bean trypsin inhibitor (Sigma} in 1 mM HCl was 
added. This mixture was immediately applied to a 
1.4 x 200 cm Sephadex G-50 column which was 
eluted with 25 mM N&HC03 @H 80). The first 
peak that eluted contained undegraded sTnC as 
well as trypsin and its inhibitor, the second peak, 
containing the proteolytic fragments, was pooled, 
freeze dried and d&o&d in 50 mM Tris-HCl, 
1 mM CaClz (pH 7-5). The different fragments 
were purified using phenyl-S~h~ose (see below), 
The yield of this preparation was 35 mg fragment 
89-159 and 14 mg fragment 9-84. 
Ca’*-dependent hydrophobic interaction and af- 
finity chromatography assays with proteolytic 
fragments (l-2 mg) were performed at room 
temperature on columns with a total volume of 
3.2 ml of phenyl-Sepharose or CAPP-Sepharose 
[12], respectively. The buffer used was 50 mM 
Tris-HCl (pH 7.5) containing either 1 mM CaClz 
or 1 mM EDTA (or EGTA) for phenylSepharose 
and for CAPP-Sepharose, the buffer was 50 mM 
242 
Tris-HCl, 5 mM CaClz or 5 mM EDTA, 0.3 M 
NaCl, 1 mM ~~mer~aptoeth~ol (pH 7.0). 
Cola-profile were assayed spectrophoto- 
metrically at 280,258 or 215 nm wavelengths and 
with non-denaturing agarose gel eleetrophoresis. 
After each determination the column was washed 
extensively with distilled water whereas an addi- 
tional wash with buffer containing 8 M urea was 
performed after every change of protein. 
Amino acid compositions were determined using 
a standard Beckman 119 CL single column 
automatic analyser with a conventional ninhydrin 
detection system. Sequence analysis was perform- 
ed on an automated Beckman sequencer (1.0 M 
Quadrol), followed by high-pressure liquid 
chromatography of the deivatised amino acids. 
3, RESULTS 
3.1. Preparation of calmodulin fragment 78-106 
Fig.1 indicates the position at which the pro- 
teolytic enzymes thrombin and trypsin cleave in- 
tact CaM in the presence of EDTA and Ca2+, 
respectively [ 18,22-251. Treatment with trypsin 
results in cleavage of the molecule into two ha&es. 
Only the carboxy-tepid peptide TR& (78-148) 
en~omp~ng the two high affinity Ca” binding 
sites is normally obtained in good yield [18], Fig.2 
shows the results obtained upon gel filtration of 
TRzC (78-148) which had been digested for 
50 min with thrombin. From the electrophoresis 
data (insert fig.1) it is obvious that the first peak 
contains both undegraded TRK (78-148) and 
TM2 (107-1481, whereas the second peak contains 
another peptide. Subsequent amino acid analysis 
(see table 1) identifies this fragment as TT 
(78-106). Thus, as with intact CaM, cleavage oc- 
curs specifically at residue Arg-106. However, TMr 
{l-106) and TM2 (107-148) are relatively stable to 
further degradation by thrombin 118,251, but TT 
(78-106) is not since it completely disappears if the 
digestion of TRzC is extended to 2 h (not shown}. 
3.2. C&urn dependent chromatogruphy of 
calmodulin and its proteoIytic fragments 
Since C&i can bind in a Ca’+-dependent man- 
ner to phenothiazine columns [11,12,29] and 
phenyl-Sepharose columns [32] (see fig.3A), we 
decided to compare the binding characteristics of a 
series of proteolytic fragments of CaM to both 
Volume 157, number 2 FEBS LETTERS July 1983 
N-AC CQOH 
Pig. 1. Schematic representation of calmodulin indicating the 4 calcium-binding domains each comprising a 
helix-loop-helix segment and the sites of proteolytic cleavage by trypsin (TR) in the presence of Cazi and thrombin 
(TM) in the presence of EDTA. 
types of cufnmns. Table 2 provides an overview of 
the results we obtained: the outcome with both 
different columns is identical. Moreover, the table 
shows that although Ca”-dependent chromato- 
graphy on phenyl-Sepharose provides a convenient 
method for the purification of the thrombic 
fragments TM1 (l-106) and TM2 (107-148) (see 
fig3B), the tryptic fragments TRtC (l-77) and 
TRzC (78-148) both bind and can thus not be 
Ol 
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Figd. Column profile obtained for a 2.5 mg sample of 
TRK (78-148) degraded for 50 mm by thrombin 
(25 LB.) on a Sephadex G-SO superfine column of 1.0 x 
36 cm. The cohrmn was eluted with 50 mM NHsHCUr 
buffer @H 8.0). The fraction sire was about LO ml. The 
insert shows an agarose gel of fractions If-14 (A-XI). 
Fractions 11 and 12 contain both TRtC (78-148) and 
TM2 (x07-148) fraction 14 contains pure TT (78-106). 
purified using this ionic strength. Possibly purifi- 
cation sit lower ionic strength or temperature will 
be possible, since we noticed that TRrC (l-77) 
bound tighter than TRzC (78-148). 
3.3. Calcium-depbdent chromatography of 
cardiac and skeletal troponin C and tryptic 
frogmen ts 
Since CaM and TnC are highly homologous pro- 
Table 1 
Ammo acid composition of the pr~~l~i~ fragments of 
CaM and sTnC” 
(7;-%6) 
TnC TnC 
(9-84) (89-159) 
Asx 4.3 (4)b 8.4 (8)’ 11.9 (12)c 
Thr 0.8 (1) 3.8 (4) 1.8 (1) 
Ser 1.5 (2) 3.4 (4) 2.6 (3) 
GLx 4.5 (5) 13.5 (13) 14.9 (13) 
Pro 0.1 (0) 0.8 (1) 0.2 (0) 
GJv 1.8 (2) 6.9 (6) 6.3 (7) 
Ala 2.4 (3) 4.7 (5) 4.6 (5) 
VaJ 1.1 (1) 5.0 (5) 2,l (2) 
Met 0.1 (I) 6.7 (72 3.2 (3) 
Be 1.7 (2) 4.5 (5) 5.0 (5) 
Leu 1.0 (1) 5.0 (5) 4.6 (4) 
TYr 0.9 (1) 0.6 (1) 0.5 (1) 
Phe 1.7 (2) 4.9 (5) 4.8 (5) 
LYS 1.2 (1) 4.2 (4) 3.8 (4) 
His 0.4 (0) 0.3 (0) 1.0 (1) 
Arg 2.4 (3) 2.0 (2) 3.5 (4) 
a Hydrolysis of peptides was performed for 24 h in 6 M 
WC1 at llO*C 
’ The number between brackets indicates the expected 
number of amino acids f1,2%] 
’ Amino acid sequencing of the first 8 ammo acids gave 
exactly the predicted sequence fZg] 
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Fig,3. (A) Cazf-dependent chromatography of CaM 
(1.1 mg) on a phenyI-Sepharose cohunn (0.7 x 20 cm). 
The arrow indicates the time when the 1 mM Ca2’ in 
the buffer was replaced by 1 mM EGTA, (B) Chromato- 
graphy (as in fig.SA) of a mixture (I.8 rng) of the 
thrombic fragments TM1 (I-K%) and TM2 (107-148). 
The insert shows an S~S-poIy~~r~l~~de gel USI 
of phenyl-Sepharose-purified CaM (a), ‘I’MI (b) and 
TM2 (cl. 
teins it seemed worthwhile to investigate 
Caz”-dependent binding of TnC to phenyl- 
Sepharose, especially since it was recently shown 
that sTnC binds similarly to immobilised 
phenothiazines [ZOj. Our results (fig4A) indicate 
Table 2 
Ca’+-dependent binding of ca~rn~~~~n proteolytic 
fragmex& 
Peptide Amino acids Phenyl- CAPP- 
Sepharose Sepharose 
TRrC l- 77 + + 
TR2C 78-148 f -I- 
TMr l-106 f + 
TM1 107-148 - _b 
TT 7&106 - _b 
* Conditions as described in se&on 2 
b About gY% of e~e~ophoreti~ly pure peptide did not 
bind, but 15% did 
Fig.4, (A) Ca’“-dependent chromatography of sTnC 
(25 mg) on a phenyl-~ph~ose column (1.5 x 15 cm). 
The arrow indicates the time when the 1 mM Ca2* in the 
buffer was replaced by I mM EDTA. (BB) 
~hromato~ap~y (~den~~~y as in fig.4A) of a mixture 
(55 mg) of the tryptic fragments of sTnC. The insert 
shows an SDS-polyacryiamide gei 1181 of phenyl- 
Sepharose-purified sTnC (a), fragment 9-84 (b) and 
fragment 84-159 (c). 
that both sTnC and cTnC (not shown) bind to the 
phenyl-Sepharose in the presence of 1 mM Ca2+. 
sTnC did not bind in the presence of 10 mM Mgzc. 
Tryptic cleavage of sTnC in the presence of Ca’” 
is reported to give rise to two fragments, 9-84 and 
89-159, each containing two complete cakium- 
binding, domains f26-281. When we applied the 
mixture of proteolytic peptides (section 2) we ob- 
tained the column profile as shown in fig.4B. Thus 
only one of the fragments binds in a 
Gaze-dependent manner to phenyl-Sepharose. This 
one was identified by amino acid analysis as the 
fragment 9-84 (see table I), whereas the other pep- 
tide is the proteolytic fragment 89-159 (see table 
1). Thus Ca2+-dependent chromatography on 
phenyl-Sepharose provides an attractive large-scale 
alternative for the purification of sTnC tryptic 
fragments, compared to the cumbersome 
preparative gel ele~trophoresis method usually 
employed [26-281. 
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4. DISCUSSION 
Although the original discoveries that anti- 
psychotic drugs [Z] and smooth muscle relaxing 
agents [3,4] bound to CaM led to the suggestion 
that specific binding sites for these agents may ex- 
ist, our studies show that identical results are ob- 
tained with phenyl- and CAPP-Sepharose, thus in- 
dicating that rather non-specific hydrophobic 
forces must be involved in the interaction between 
the drugs and the Ca’+-dependent domains on the 
surface of CaM. Similar conclusions, based on dif- 
ferent types of experiments, have been put forward 
[9,14,15]. Be that as it may, since the binding of 
such agents often prevents the interaction between 
CaM and its receptor proteins [l-3], they provide 
a useful tool for studying the molecular 
mechanisms of Ca2+-regulatory events. 
CaM is reported to contain two high affinity 
binding sites for TFP [2,16,19,33]. Since both 
fragments TRiC (l-77) and TR& (78-148) bind 
in a Ca’+-dependent manner to phenyl- and 
CAPP-Sepharose (see table 2) it appears that each 
half of the molecule contains one high affinity 
binding site for phenothiazines. Since the fragment 
TM2 (lo%- 148), which still has considerable affini- 
ty for metal ions [18], does not bind, it is unlikely 
that one of the TFP binding sites is not solely 
located on the carboxy-terminal a-helix of 
calmodulin as had been suggested [33). Rather 
since TR2C (78-148) does bind but not TT 
(78-106) and TM2 (107-148) (see table 2), it ap- 
pears that the carboxy-terminal a-helix of calcium 
binding domain III could comprise one binding 
site, and that proteolytic cleavage at position 106 
destroys it. An alternative explanation of these 
results would be that the hydrophobic site is 
located on the a-helix preceding site fII and that 
the affinity of the fragment TT for Ca2’ is too low 
to assure proper folding. Finally, the possibility 
that the site is composed of different stretches of 
amino acids that are brought in proximity due to 
protein folding cannot be excluded. Interestingly, 
a cyanogen bromide fragment 77-124 was also re- 
tained in a Ca2+-dependent manner on a CAPP- 
Sepharose column [34] and TR2C (78-148), but 
not TM2 (107- 148) activated phosphorylase kinase 
1231. It is not clear at present what specific amino 
acids would contribute to the hydrophobic site, 
although proton NMR 119,331 data suggested that 
phenylalanine, methionine and methyl groups are 
involved. 
Our observation that only the Gino-te~inal 
half of sTnC exposes a hydrophobic surface upon 
Ca” binding (fig4A) is somewhat surprising, 
since recently evidence was provided for binding of 
TFP to the amino-terminal a-helix of calcium 
binding domain III [35]. However, this obser- 
vation is consistent with the finding that the 
presence of 10 mM M2+ does not induce binding 
of sTnC to phenyl-Sepharose. This cation would 
bind only. to the high affinity calcium binding sites 
III and IV 1261. Thus binding of Ca” to the two 
low affinity Ca2’-specific sites I and II is apparent- 
ly a necessity for the exposure of the hydrophobic 
surface on the amino-terminal half of the protein 
molecule. This particular hydrophobic domain is 
probably invoived in the interaction between TnC 
and troponin I (TnI), since it has been reported 
that this fragment and TnI are capable of forming 
a Ca2+-dependent complex in solution [26,27]. 
Our studies have shown that Ca”-dependent 
chromatography on phenyl-Sepharose provides a 
convenient method for purification of CaM (321, 
cTnC, sTnC as well as some of their proteolytic 
fragments (fig.3,4). In addition, metal ion- 
dependent hy~ophobic interaction chromatogra- 
phy has recently been used for pu~fi~tion of 
other calcium-binding proteins like SlOO [36] and 
fr-lactalbumin [37]. The latter binds, in contrast to 
all other calcium binding proteins studied to date, 
in the presence of EDTA and is eluted upon addi- 
tion of Ca”’ [37]. One note of caution should be 
extended, however. When phenyl-Sepharose was 
used for the purification of sTnC immediately 
after the first ion-exchange step 1291 we noticed 
proteolytic breakdown which was probably caused 
by co-purification of Ca2+-dependent proteases 
[38], Fu~ermore, we observed that sTnC purified 
using phenyl-Sepharose as a last chromatography 
step was somewhat less stable upon storage than 
normal preparations. These problems are currently 
under investigation in our laboratory. 
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